Key Details
Price
$4.27Annual ROE
-12.36%Beta
0.94Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
June 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 20, 2024Analyst ratings
Recent major analysts updates
Screeners with ACB included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NASDAQ | TSX: ACB The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB , Dec. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia's leading portfolio of products under the CraftPlant, Aurora, and IndiMed brands, furthering the mission to expand access for Australian patients.
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.50 per share a year ago.
Aurora Cannabis Inc. (NASDAQ:ACB ) Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - CEO Simona King - CFO Conference Call Participants Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Operator Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only mode and a question-and-answer session will follow the formal presentation.
NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB , Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director.
24/7 Wall St. Insights A Kamala Harris victory in the 2024 presidential election could provide a boost for stocks in a variety of sectors.
Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.
When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.
Aurora Cannabis Inc (NASDAQ:ACB) and Lumen Technologies Inc (NYSE:LUMN) are this week's picks for Schaeffer's Cheap Seats : Stocks Under $20 segment.
Investing in top marijuana stocks in 2024 can be a bit of a challenge. Sometimes it can be tough knowing which companies to consider and when to take action. For many no matter the sector investing is a skill that takes time to get right. To begin if you are new to marijuana stocks some factors to keep in mind. Most of the sector operates with a large amount of volatility.
Company's Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Research EDMONTON, AB , July 25, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). Aurora's license grants the company continued domestic cultivation, which has been underway for two years now.
FAQ
- What is the primary business of Aurora Cannabis?
- What is the ticker symbol for Aurora Cannabis?
- Does Aurora Cannabis pay dividends?
- What sector is Aurora Cannabis in?
- What industry is Aurora Cannabis in?
- What country is Aurora Cannabis based in?
- When did Aurora Cannabis go public?
- Is Aurora Cannabis in the S&P 500?
- Is Aurora Cannabis in the NASDAQ 100?
- Is Aurora Cannabis in the Dow Jones?
- When was Aurora Cannabis's last earnings report?
- When does Aurora Cannabis report earnings?